A simple blood draw can provide physicians with valuable information that can determine if peptide receptor radionuclide therapy (PRRT) is likely to be effective in a patient with neuroendocrine cancer.
Apr 6, 2023
0
0
Detailed PSMA PET mapping of cancer recurrence in the prostate bed shows that current radiotherapy contouring guidelines—which determine the target areas for treatment—miss a significant number of lesions and may irradiate ...
Mar 24, 2023
0
5
A new molecular imaging radiotracer can precisely diagnose a variety of cancers, providing a roadmap to identify patients who may benefit from targeted radionuclide therapies. In the largest medical study of its kind, researchers ...
Nov 17, 2022
0
49
Nearly 70% of breast cancer patients could find out if their cancer has spread to their lymph nodes without having to undergo an invasive sentinel node biopsy. New research published ahead of print in the Journal of Nuclear ...
Nov 10, 2022
0
27
A new highly selective PET imaging agent can detect the presence of overexpressed monoamine oxidase-B (MAO-B) in cognitively unimpaired individuals with high beta amyloid (Ab)—one of the earliest signs of Alzheimer's disease—according ...
Oct 19, 2022
0
27
Total body PET/CT scans can successfully visualize systemic joint involvement in patients with autoimmune arthritis, according to new first-in-human research published in the October issue of the Journal of Nuclear Medicine. ...
Oct 13, 2022
0
4
A significant number of COVID-19 neurological complications— such as fatigue, headache, and cognitive impairment—are ultimately reversible, according to new research summarized by the Journal of Nuclear Medicine. The ...
Mar 17, 2022
0
101
The Journal of Nuclear Medicine's September 2017 supplement shines a spotlight on theranostics and its increasingly important role in the delivery of precision medicine. Theranostics refers to the combination of a predictive ...
Sep 13, 2017
0
1
Researchers have demonstrated a new, effective way to precisely identify and localize prostate cancer tumors while protecting healthy tissue and reducing side effects. The new approach utilizes a single molecule designed ...
Sep 7, 2017
0
3
Advanced melanoma, a type of skin cancer that has spread to other areas of the body, has a poor prognosis, but immune checkpoint inhibitor therapy can be effective for some patients. Research highlighted in the featured article ...
Sep 5, 2017
1
6
